NCT05995860Completed
Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery
Pilot Study of a Rapid Triadic Communication Intention Elicitation Intervention (PRECursOr) to Improve Supportive Oncology Care Delivery for Patients With Advanced, Incurable Cancer and Their Caregivers
Source: ClinicalTrials.gov · Last updated 28 Jan 2025
Brief summary (registry, in English)
The purpose of this study is to help test an idea designed to foster more supportive talk between providers (doctors or nurse practitioners), patients, and caregivers during an outpatient oncology appointment. A caregiver is the person the patient identifies is primarily involved in their healthcare. This study is collecting your reaction to this idea in order to understand needed changes before we introduce the idea to a larger group of patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 47 (actual)
- First submitted
- 10 Jul 2023
- Start date
- 14 Jun 2023
- Primary completion date
- 9 Jan 2025
- Lead sponsor
- Indiana University
- Diseases
- Ovarian cancer
- NCT number
- NCT05995860
What you commit to
- Study type: Interventional
- Participants enrolled: 47
- From 14 Jun 2023 to the primary completion date, 9 Jan 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- cognitive impairment, or
Other
- patients and/or caregivers will be excluded if either one or both demonstrate:
- speech/hearing difficulties precluding participation.
Who the study is looking for
- patients will:
- be adult women with an incurable gynecologic cancer (i.e., evidence of refractory/progressive disease after first-line treatment or recurrent disease),
- not be receiving specialty palliative care or hospice,
- read/speak English, and
- be able to provide written informed consent.
- caregivers will:
- identify as the individual who is primarily involved in the patient's care,
- be able to attend the oncology encounter,
- read/speak English, and
- be able to provide written informed consent.
- providers will:
- specialize in gynecologic oncology, and
- provide outpatient care at IUSCCC gynecologic oncology clinic.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IU Health Joe and Shelly Schwarz Cancer Center Coordinator of this site? Confirm its status | Carmel | United States | Unknown status |
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.